Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125228362 | 12522836 | 2 | F | 201501 | 20160905 | 20160701 | 20160907 | EXP | PHHY2016AR090249 | NOVARTIS | 84.00 | YR | F | Y | 0.00000 | 20160907 | CN | AR | AR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125228362 | 12522836 | 1 | PS | STARLIX | NATEGLINIDE | 1 | Unknown | (1/2 OR 1/3) DF, QD | 21204 | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125228362 | 12522836 | 1 | Diabetes mellitus |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125228362 | 12522836 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125228362 | 12522836 | Gastritis | |
125228362 | 12522836 | Logorrhoea | |
125228362 | 12522836 | Thrombosis | |
125228362 | 12522836 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125228362 | 12522836 | 1 | 2008 | 0 |